Navigation Links
New studies suggest airborne SARS transmission is possible

l precautions to prevent SARS coronavirus transmission in the health care setting.

In the Hong Kong study, which focused on the 2003 SARS outbreak at the Prince of Wales Hospital, 41 percent of patients admitted to the ward in which the first SARS patient was staying became infected. Proximity to the bed of the first case seemed to be strongly linked with incidence of infection-two-thirds of patients in the same bay and half of patients in an adjacent bay were infected with SARS, while only 18 percent of patients in distant bays were infected.

The Hong Kong researchers, led by Ignatius T.S. Yu, MBBS, MPH, of the Chinese University of Hong Kong, speculate that the increased risk of infection with closer proximity to the index SARS case suggests airborne transmission. Although they do not have "direct proof" of airborne transmission, according to Dr. Yu, "no other known routes of infectious diseases transmission could adequately explain the spread of the disease in the outbreak, and hence we feel that the evidence is quite strong."

An editorial accompanying the Toronto study, by Tommy Tong, MBBS, of Princess Margaret Hospital in Hong Kong, emphasized the scientific significance of discovering SARS coronavirus in the air in a patient's room. "Although the possibility of airborne dissemination of SARS coronavirus has been controversial," said Dr. Tong, "this important work shows beyond doubt that SARS coronavirus aerosol generation can occur from a patient with SARS." The Hong Kong study provides additional, complementary evidence that the virus may be capable of spreading through the air.


'"/>

Source:Infectious Diseases Society of America


Page: 1 2

Related biology news :

1. Two studies document rise of superbugs in the environment
2. UI researcher studies deafness in fruit flies, humans
3. Biased reporting found in cancer prognostic studies
4. Fruit fly studies open new window on cancer research
5. Why do aneurysms form? New studies suggest leading role for white blood cells
6. Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies
7. Diabetes researchers pioneer islet cell xenotransplantation in primate studies
8. Pair of studies offer new clues to combat antibiotic resistance
9. New RNAi tools enable systematic studies of gene function
10. Ernst Mayrs theory illustrated in genetic epidemiology studies
11. Mice studies illustrate potential of chimp/human antibodies to protect against smallpox
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New studies suggest airborne SARS transmission possible

(Date:9/23/2014)... their own "antifreeze" proteins to survive in the ... effect, researchers funded by the National Science Foundation ... inside their bodies resist melting even when temperatures ... be an undesirable consequence of the evolution of ... of Oregon doctoral student Paul Cziko, who led ...
(Date:9/23/2014)... multidisciplinary team at the University of Wisconsin-Madison and the ... affordable way to screen for neural toxins, helping flag ... Institutes of Health (NIH) announced today that the UW-Madison ... to continue the promising work as part of the ... receive approximately $7 million over the three-year project. ...
(Date:9/23/2014)... (PHILADELPHIA) Researchers have encountered variants or isoforms in ... accidental byproducts. A recent study, published in the journal ... called isomiRs have abundances that depend on geographic subpopulations ... a given miRNA may not be the one typically ... that microRNA isoforms are much more common than we ...
Breaking Biology News(10 mins):Antifreeze proteins in Antarctic fish prevent both freezing and melting 2Antifreeze proteins in Antarctic fish prevent both freezing and melting 3UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3
... at St. Jude Children's Research Hospital have discovered how a ... effects ranging from learning and memory capabilities to glucose production ... called CREB, is a transcription factor—a molecule that binds to ... gene to make the specific protein for which it codes. ...
... provides the most compelling evidence to-date that some dinosaurs ... del Campo track site in Spain's Cameros Basin, contains ... a non-avian therapod dinosaur. , A team led ... La Rioja, Spain, discovered the prints in an area ...
... guys that help bacterial pathogens do their job of infecting ... essence, they knock down the front door of resistance and ... University of California, San Diego (UCSD) School of Medicine have ... YpkA, one of several effectors of the bacteria Yersinia – ...
Cached Biology News:St. Jude study shows genes play an unexpected role in their own activation 2Definitive evidence found of a swimming dinosaur 2How plague-causing bacteria disarm host defense 2
(Date:9/23/2014)... 23, 2014 Proove Biosciences , ... industry leading research and data on the association between ... American Academy of Pain Management’ s 25th ... Arizona at the , Proove Biosciences ... and genetic predisposition to opioid misuse risk in chronic ...
(Date:9/23/2014)... 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... pleased to announce that its wholly owned subsidiary, ... consultants to its team for further development of ... proprietary cell permeable peptide platform technology derived from ... the eye. Ms. Holly ...
(Date:9/23/2014)... Austin, TX (PRWEB) September 23, 2014 ... newest fertility clinic in South Austin, expanding a Central ... Austin and San Antonio. The satellite office for the ... and andrology options to the South Austin, Buda, Kyle ... bring effective and affordable fertility treatment directly to individuals ...
(Date:9/23/2014)... 2014 New spin-out from ... Cambridge Innovation Capital and Johnson & Johnson Development ... company focused on harnessing the potential of circulating ... and treatment, today announced it has raised £4m ... and including Cambridge Innovation Capital and Johnson & ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3Portage Announces New Consultants for its PPL-003 Development Programs 2Portage Announces New Consultants for its PPL-003 Development Programs 3Portage Announces New Consultants for its PPL-003 Development Programs 4Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4
... of investigational sustained follicle stimulant achieves similar efficacy to ... week period in Phase III Study , , ... SGP ) today announced results from the Phase III ... corifollitropin alfa, first in the class of sustained follicle ...
... a subsidiary of Eisai Corporation of North America, announced ... express and develop therapeutic monoclonal antibodies for the potential ... , , Under the terms of the agreement, ... technology and its expertise to produce and develop a ...
... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that ... device and methods for linking biological agents to labels for ... as In-Line labeling, was developed for the production of radiolabeled ... A study published today in the July 2009 issue ...
Cached Biology Technology:Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease 2Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 4
Request Info...
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
in vitro Translation, Accessory Products...
... Origami host strains are K-12 derivatives ... reductase (trxB) and glutathione reductase (gor) genes, ... the cytoplasm. Studies have shown that expression ... than in another host even though overall ...
Biology Products: